Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
J Cell Biol ; 160(7): 1009-15, 2003 Mar 31.
Artículo en Inglés | MEDLINE | ID: mdl-12668656

RESUMEN

The uptake and lysosomal degradation of collagen by fibroblasts constitute a major pathway in the turnover of connective tissue. However, the molecular mechanisms governing this pathway are poorly understood. Here, we show that the urokinase plasminogen activator receptor-associated protein (uPARAP)/Endo180, a novel mesenchymally expressed member of the macrophage mannose receptor family of endocytic receptors, is a key player in this process. Fibroblasts from mice with a targeted deletion in the uPARAP/Endo180 gene displayed a near to complete abrogation of collagen endocytosis. Furthermore, these cells had diminished initial adhesion to a range of different collagens, as well as impaired migration on fibrillar collagen. These studies identify a central function of uPARAP/Endo180 in cellular collagen interactions.


Asunto(s)
Colágeno/metabolismo , Endocitosis , Fibroblastos/metabolismo , Glicoproteínas de Membrana/metabolismo , Receptores de Superficie Celular/metabolismo , Animales , Adhesión Celular/efectos de los fármacos , Movimiento Celular/efectos de los fármacos , Movimiento Celular/fisiología , Células Cultivadas , Colagenasas/metabolismo , Fibronectinas/metabolismo , Eliminación de Gen , Metaloproteinasa 13 de la Matriz , Glicoproteínas de Membrana/química , Glicoproteínas de Membrana/genética , Ratones , Receptores de Superficie Celular/química , Receptores de Superficie Celular/deficiencia , Receptores de Superficie Celular/genética , Receptores Mitogénicos/química , Receptores Mitogénicos/deficiencia , Receptores Mitogénicos/genética , Receptores Mitogénicos/metabolismo , Receptores del Activador de Plasminógeno Tipo Uroquinasa , Transferrina/metabolismo
2.
Pediatr Dent ; 28(4): 375-80, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-16903449

RESUMEN

PURPOSE: The purpose of this study was to examine the relationship between age-specific body mass index (BMI-for-age) and dental caries among US children. METHODS: Body measures data and oral health data came from the 1999-2002 National Health and Nutrition Examination Survey. Outcome measures for primary and permanent dentitions were: (1) dental caries prevalence; and (2) severity (geometric mean dft and DMFT). Covariates included: (1) age; (2) gender; (3) race/ethnicity; and (4) poverty status. Analysis was limited to children 2 to 17 years old. RESULTS: Approximately 36% of overweight children 2 to 6 years old and 39% of overweight children 6 to 17 years old had dental caries. Geometric mean dental caries scores for overweight children were dft=3.3 and DMFT=2.5 for primary and permanent dentitions, respectively. Controlling for covariates, there was no significant association between BMI-for-age and dental caries prevalence in either dentition. In addition, among children with a positive history of dental caries, BMI-for-age was significantly associated with dental caries severity in the permanent dentition - overweight children had a lower geometric mean DMFT than did normal weight children. CONCLUSIONS: Although it was hypothesized that age-specific body mass index would be associated with increased dental caries prevalence and severity, these associations were not found. Rather, overweight was found to be associated with lower geometric mean DMFT. Future studies should address which factors specific to overweight in children might be protective against dental caries in the permanent dentition. Given the importance of overweight as a public health problem, however, clinicians are encouraged to continue providing health education and dietary counseling to their overweight child patients.


Asunto(s)
Caries Dental/complicaciones , Obesidad/complicaciones , Adolescente , Factores de Edad , Índice de Masa Corporal , Niño , Preescolar , Índice CPO , Caries Dental/epidemiología , Etnicidad , Femenino , Humanos , Modelos Lineales , Masculino , Obesidad/epidemiología , Oportunidad Relativa , Prevalencia , Factores Sexuales , Clase Social , Estados Unidos/epidemiología
3.
Oncogene ; 21(57): 8830-42, 2002 Dec 12.
Artículo en Inglés | MEDLINE | ID: mdl-12483535

RESUMEN

The specific functions of plasminogen, stromal plasminogen activator, stromal plasminogen activator receptor, and stromal plasminogen activator inhibitor in the progression of the murine soft tissue sarcoma, T241 were investigated. Negation of plasminogen to the tumor blunted the orthotopic growth of the sarcoma in syngeneic mice. The reduced tumor growth was associated with a dramatic increase in tumor-infiltrating F4/80-positive macrophages and a diminution of vessel density, but not with obvious differences in fibrin and collagen deposition, or invasiveness of the tumor. Ablation of plasminogen activation by the tumor stroma only modestly impaired the prolonged growth of the sarcoma, suggesting that tumor cell-produced plasminogen activator is sufficient to mediate productive plasminogen activation. Plasminogen facilitated sarcoma progression, angiogenesis, and suppression of macrophage infiltration in the absence of either stromal urokinase plasminogen activator receptor or stromal plasminogen activator inhibitor. These data demonstrate that tumor cell-produced plasminogen activator and host plasminogen cooperate to facilitate soft tissue sarcoma growth and suppress the accumulation of tumor-infiltrating macrophages.


Asunto(s)
División Celular/fisiología , Macrófagos/citología , Plasminógeno/fisiología , Sarcoma/patología , Neoplasias de los Tejidos Blandos/patología , Animales , Secuencia de Bases , Cartilla de ADN , Ratones , Ratones Endogámicos C57BL
4.
Proc Natl Acad Sci U S A ; 100(2): 657-62, 2003 Jan 21.
Artículo en Inglés | MEDLINE | ID: mdl-12525700

RESUMEN

The acquisition of cell-surface urokinase plasminogen activator activity is a hallmark of malignancy. We generated an engineered anthrax toxin that is activated by cell-surface urokinase in vivo and displays limited toxicity to normal tissue but broad and potent tumoricidal activity. Native anthrax toxin protective antigen, when administered with a chimeric anthrax toxin lethal factor, Pseudomonas exotoxin fusion protein, was extremely toxic to mice, causing rapid and fatal organ damage. Replacing the furin activation sequence in anthrax toxin protective antigen with an artificial peptide sequence efficiently activated by urokinase greatly attenuated toxicity to mice. In addition, the mutation conferred cell-surface urokinase-dependent toxin activation in vivo, as determined by using a panel of plasminogen, plasminogen activator, plasminogen activator receptor, and plasminogen activator inhibitor-deficient mice. Surprisingly, toxin activation critically depended on both urokinase plasminogen activator receptor and plasminogen in vivo, showing that both proteins are essential cofactors for the generation of cell-surface urokinase. The engineered toxin displayed potent tumor cell cytotoxicity to a spectrum of transplanted tumors of diverse origin and could eradicate established solid tumors. This tumoricidal activity depended strictly on tumor cell-surface plasminogen activation. The data show that a simple change of protease activation specificity converts anthrax toxin from a highly lethal to a potent tumoricidal agent.


Asunto(s)
Antígenos Bacterianos , Antineoplásicos/farmacología , Toxinas Bacterianas/farmacología , Neoplasias Experimentales/tratamiento farmacológico , Ingeniería de Proteínas , Activador de Plasminógeno de Tipo Uroquinasa/metabolismo , Animales , Toxinas Bacterianas/metabolismo , Toxinas Bacterianas/uso terapéutico , Sistemas de Liberación de Medicamentos , Furina , Ratones , Plasminógeno/fisiología , Receptores de Superficie Celular/fisiología , Receptores del Activador de Plasminógeno Tipo Uroquinasa , Proteínas Recombinantes/farmacología , Subtilisinas/metabolismo
5.
J Biol Chem ; 277(47): 45154-61, 2002 Nov 22.
Artículo en Inglés | MEDLINE | ID: mdl-12192005

RESUMEN

Matrix metalloproteinase-14 is required for degradation of fibrillar collagen by mesenchymal cells. Here we show that keratinocytes use an alternative plasminogen and matrix metalloproteinase-13-dependent pathway for dissolution of collagen fibrils. Primary keratinocytes displayed an absolute requirement for serum to dissolve collagen. Dissolution of collagen was abolished in plasminogen-depleted serum and could be restored by the exogenous addition of plasminogen. Both plasminogen activator inhibitor-1 and tissue inhibitor of metalloproteinase blocked collagen dissolution, demonstrating the requirement of both plasminogen activation and matrix metalloproteinase activity for degradation. Cell surface plasmin activity was critical for the degradation process as aprotinin, but not alpha(2)-antiplasmin, prevented collagen dissolution. Keratinocytes with single deficiencies in either urokinase or tissue plasminogen activator retained the ability to dissolve collagen. However, collagen fibril dissolution was abolished in keratinocytes with a combined deficiency in both urokinase and tissue plasminogen activator. Combined, but not single, urokinase and tissue plasminogen activator deficiency also completely blocked the activation of the fibrillar collagenase, matrix metalloproteinase-13, by keratinocytes. The activation of matrix metalloproteinase-13 in normal keratinocytes was prevented by plasminogen activator inhibitor-1 and aprotinin but not by tissue inhibitor of metalloproteinase-1 and -2, suggesting that plasmin activates matrix metalloproteinase-13 directly. We propose that plasminogen activation facilitates keratinocyte-mediated collagen breakdown via the direct activation of matrix metalloproteinase-13 and possibly other fibrillar collagenases.


Asunto(s)
Colágeno/metabolismo , Colagenasas/metabolismo , Queratinocitos/metabolismo , Plasminógeno/metabolismo , Animales , Animales Recién Nacidos , Células Cultivadas , Medio de Cultivo Libre de Suero , Activación Enzimática , Femenino , Fibroblastos/citología , Fibroblastos/metabolismo , Marcación de Gen , Humanos , Queratinocitos/citología , Masculino , Metaloproteinasa 13 de la Matriz , Metaloproteinasas de la Matriz Asociadas a la Membrana , Metaloendopeptidasas/metabolismo , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Inhibidor 1 de Activador Plasminogénico/metabolismo , Activadores Plasminogénicos/genética , Receptores de Superficie Celular/genética , Receptores del Activador de Plasminógeno Tipo Uroquinasa , Inhibidores de Serina Proteinasa/metabolismo , Inhibidores Tisulares de Metaloproteinasas/metabolismo , Activador de Tejido Plasminógeno/genética , Activador de Plasminógeno de Tipo Uroquinasa/genética
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda